HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies

Tracey, Creedon, Kemp, Culley, Muir, Klinowska, Brunton (2020) HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies Breast Cancer Res Treat (IF: 3.8) 179(3) 543-555
Full Text
Full text

Click the PDF icon to view the full text of the paper

Abstract

Targeted therapies have resulted in major advances in the treatment of HER2-positive breast cancers. Despite this, up to 70% of patients will develop resistance to treatment within 2 years and new strategies for targeting resistant disease are needed.To identify potential resistance mechanisms, we used the mouse MMTV-NIC-PTEN+/- spontaneous model of HER2-positive breast cancer and the pan-HER family kinase inhibitor sapatinib. Vehicle and sapatinib-treated tumors were evaluated by immunohistochemistry and proteomic analysis. In vitro studies were carried out to define the role of heme oxygenase 1 (HO-1) and autophagy in resistance to sapatinib and lapatinib, another pan-HER family kinase inhibitor.Treatment of tumor-bearing MMTV-NIC-PTEN+/- mice with sapatinib resulted in delayed tumor progression and increased survival. However, tumors eventually progressed on treatment. Proteomic analysis identified proteins associated with cellular iron homeostasis as being upregulated in the sapatinib-treated tumors. This included HO-1 whose overexpression was confirmed by immunohistochemistry. Overexpression of HO-1 in HER2-expressing SKBR3 breast cancer cells resulted in reduced sensitivity to both pan-HER family kinase inhibitors sapatinib and lapatinib. This was associated with increased autophagy in the HO-1 over-expressing cells. Furthermore, increased autophagy was also seen in the sapatinib-treated tumors. Treatment with autophagy inhibitors was able to increase the sensitivity of the HO-1 over-expressing cells to both lapatinib and sapatinib.Together these data indicate a role for HO-1-induced autophagy in resistance to pan-HER family kinase inhibitors.

Links

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997276
http://www.ncbi.nlm.nih.gov/pubmed/31705351
http://dx.doi.org/10.1007/s10549-019-05489-1

Similar articles

Tools